new oral cancer drugs, Nexavar and Sutent

March 2006

You'll see two new oral cancer drugs, Nexavar and Sutent.

These drugs work similarly to Gleevec (imatinib). They block proteins involved in a tumor's growth and blood supply.

But Nexavar and Sutent target a wider range of proteins.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

  • Cutting-edge advice about new medications and how they fit into practice
  • Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
  • Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote